GE HealthCare Earnings Estimate

GEHC Stock   80.34  1.69  2.15%   
The next projected EPS of GE HealthCare is estimated to be 1.0604 with future projections ranging from a low of 0.9225 to a high of 1.249. GE HealthCare's most recent 12-month trailing earnings per share (EPS TTM) is at 4.55. Please be aware that the consensus of earnings estimates for GE HealthCare Technologies is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
GE HealthCare is projected to generate 1.0604 in earnings per share on the 31st of March 2026. GE HealthCare earnings estimates show analyst consensus about projected GE HealthCare Technologies EPS (Earning Per Share). It derives the highest and the lowest estimates based on GE HealthCare's historical volatility. Many public companies, such as GE HealthCare, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

GE HealthCare Revenue Breakdown by Earning Segment

By analyzing GE HealthCare's earnings estimates, investors can diagnose different trends across GE HealthCare's analyst sentiment over time as well as compare current estimates against different timeframes. At present, GE HealthCare's Operating Profit Margin is projected to increase slightly based on the last few years of reporting. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GE HealthCare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

GE HealthCare Earnings Estimation Breakdown

The calculation of GE HealthCare's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of GE HealthCare is estimated to be 1.0604 with the future projection ranging from a low of 0.9225 to a high of 1.249. Please be aware that this consensus of annual earnings estimates for GE HealthCare Technologies is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
1.29
0.92
Lowest
Expected EPS
1.0604
1.25
Highest

GE HealthCare Earnings Projection Consensus

Suppose the current estimates of GE HealthCare's value are higher than the current market price of the GE HealthCare stock. In this case, investors may conclude that GE HealthCare is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and GE HealthCare's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2026Current EPS (TTM)
2191.63%
1.29
1.0604
4.55

GE HealthCare Earnings History

Earnings estimate consensus by GE HealthCare Techno analysts from Wall Street is used by the market to judge GE HealthCare's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only GE HealthCare's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

GE HealthCare Quarterly Gross Profit

2.54 Billion

As of February 14, 2026, Retained Earnings is expected to decline to about 2.7 B. In addition to that, Earnings Yield is expected to decline to 0.05 The current year's Common Stock Shares Outstanding is expected to grow to about 502.1 M, whereas Net Income Applicable To Common Shares is forecasted to decline to about 1.6 B.
Hype
Prediction
LowEstimatedHigh
78.4780.3482.21
Details
Intrinsic
Valuation
LowRealHigh
72.3186.5588.42
Details
21 Analysts
Consensus
LowTargetHigh
84.8693.25103.51
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as GE HealthCare. Your research has to be compared to or analyzed against GE HealthCare's peers to derive any actionable benefits. When done correctly, GE HealthCare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in GE HealthCare Techno. Note that many institutional investors and large investment bankers can move markets due to the volume of GEHC assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards GE HealthCare. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving GE HealthCare's stock price in the short term.

GE HealthCare Earnings per Share Projection vs Actual

Actual Earning per Share of GE HealthCare refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering GE HealthCare Technologies predict the company's earnings will be in the future. The higher the earnings per share of GE HealthCare, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

GE HealthCare Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as GE HealthCare, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of GE HealthCare should always be considered in relation to other companies to make a more educated investment decision.

GEHC Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact GE HealthCare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2026-02-04
2025-12-311.411.29-0.12
2025-10-29
2025-09-301.041.070.03
2025-07-30
2025-06-300.921.060.1415 
2025-04-30
2025-03-310.911.010.110 
2025-02-13
2024-12-311.261.570.3124 
2024-10-30
2024-09-301.051.140.09
2024-07-31
2024-06-300.981.00.02
2024-04-30
2024-03-310.910.9-0.01
2024-02-06
2023-12-311.071.180.1110 
2023-10-31
2023-09-300.90.990.0910 
2023-07-25
2023-06-300.870.920.05
2023-04-25
2023-03-310.790.850.06
2023-01-30
2022-12-311.061.210.1514 
2022-12-08
2022-09-3001.111.11
2022-09-13
2022-06-3001.91.9

About GE HealthCare Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of GE HealthCare earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current GE HealthCare estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as GE HealthCare fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings5.3 B2.7 B
Earnings Yield 0.06  0.05 
Price Earnings Ratio 17.97  11.90 
Price Earnings To Growth Ratio(1.14)(1.08)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether GE HealthCare Techno offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GE HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ge Healthcare Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ge Healthcare Technologies Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GE HealthCare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Will Health Care Equipment & Supplies sector continue expanding? Could GEHC diversify its offerings? Factors like these will boost the valuation of GE HealthCare. Market participants price GEHC higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every GE HealthCare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.18)
Dividend Share
0.14
Earnings Share
4.55
Revenue Per Share
45.23
Quarterly Revenue Growth
0.071
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, GE HealthCare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.